Validation, Routine Control, and Maintaining the Effectiveness of Radiation Sterilization (ISO 11137) and Ethylene Oxide Sterilization (ISO 11135) (2 Days)

Document Control

Item Description Item Description
Course Code RS-EO-VAL-2D Version 1.0
Duration 2 days (approx. 14 hours) Delivery Classroom / Virtual (with breakout exercises)
Target Audience Sterilization engineers, QA/RA, validation personnel, auditors, service providers, technical experts-in-training Prerequisites Basic microbiology & QMS awareness recommended
Reference Standards ISO 11137 series; ISO 11135:2014; ISO 11737 series; ISO 10993-7; ISO 13485 (as applicable) Assessment Knowledge checks, workshop outputs, optional quiz

 

1. Course Overview

This 2-day program provides practical guidance to plan, execute, and sustain compliant sterilization validation and routine control for two widely used terminal sterilization technologies: radiation sterilization and ethylene oxide (EO) sterilization. The content is aligned to the key requirements and intent of ISO 11137 (Parts 1, 2 and 3) and ISO 11135:2014, with emphasis on: 

  1. establishing and maintaining a validated process, 
  2. effective routine monitoring and control, and 
  3. maintaining effectiveness through change control, requalification, and product/facility lifecycle management.

2. Learning Objectives

  • Explain the ISO 11137 and ISO 11135 process validation frameworks and how they integrate with an ISO 13485 QMS.
  • Define product families, challenge/product configurations, and worst-case rationales for validation planning.
  • Select and justify validation approaches (radiation: Method 1/VDmax/Method 2; EO: product/family approach) based on risk and evidence.
  • Design a robust qualification strategy (IQ/OQ/PQ, including MPQ/PPQ where applicable) and define acceptance criteria.
  • Establish routine control requirements: monitoring, release, alerts/actions, and periodic verification.
  • Implement an effective ongoing effectiveness program: change control, revalidation triggers, bioburden/sterility assurance reviews, and trend analysis.
  • Prepare audit-ready documentation packages, including protocols, reports, and objective evidence for conformity assessment.

3. Training Approach and Methods

  • Instructor-led explanation with standard-aligned examples
  • Group workshops (validation planning, acceptance criteria, decision trees)
  • Case studies (realistic scenarios for deviations and changes)
  • Short knowledge checks at the end of major modules
  • Optional final quiz and discussion of answers

4. Detailed Training Content

A1. ISO Framework & Sterilization Validation Lifecycle (ISO 11137 / ISO 11135)

Suggested duration: 1.0-1.25 h

Learning outcomes:

  • Differentiate validation, qualification, routine control, and ongoing process effectiveness activities.
  • Explain key terms: sterilization process, SAL, bioburden, product family, load configuration, critical process parameters.
  • Describe how sterilization requirements interface with QMS processes (design transfer, purchasing, production controls, CAPA, change control).

Content outline:

  • Overview of terminal sterilization technologies and when each is applied (radiation vs EO).
  • Sterility assurance concept: SAL, microbial inactivation, and sources of variability.
  • ISO standard structure and intent: ISO 11137 Parts 1-3 and ISO 11135:2014 (high-level map).
  • Validation lifecycle model: development, validation (IQ/OQ/PQ), routine control, maintenance, and change management.
  • Regulatory and audit expectations: demonstrating objective evidence and traceability.

Workshop / exercise:

Short pre-assessment and group discussion: identify current gaps/risks in your facility’s sterilization lifecycle controls.

Expected outputs:

  • List of site-specific learning goals
  • Top 5 current challenges to address during the course
A2. Radiation Sterilization – Validation Planning (ISO 11137-1/-2/-3)

Suggested duration: 1.5 h

Learning outcomes:

  • Define product family and select representative/worst-case configurations for dose setting and dose mapping.
  • Select a dose setting method (e.g., Method 1, VDmax, Method 2) based on product characteristics and available data.
  • Develop a validation plan that includes bioburden sampling, dose mapping, and verification dose experiments.

Content outline:

  • Radiation process definition: modality (gamma/e-beam/x-ray), dose delivery, dose uniformity ratio (DUR) concept.
  • Pre-validation inputs: product definition, packaging system, materials compatibility, and functional/performance considerations.
  • Bioburden strategy (ISO 11737-1): sampling plan, lab controls, seasonal variation, and family grouping.
  • Dose setting overview: method selection logic, assumptions, and data requirements (high-level).
  • Dose mapping strategy: location selection, minimum/maximum dose, routine dosimeter locations, load patterns.
  • Validation plan structure: responsibilities, risk assessment, acceptance criteria, and data integrity.

Workshop / exercise:

Workshop: build a product family and worst-case rationale. Draft a one-page radiation validation plan outline (dose setting + dose mapping).

Expected outputs:

  • Product family definition and rationale
  • Draft validation plan outline with acceptance criteria
A3. Radiation Sterilization – Qualification and Performance Qualification

Suggested duration: 1.25-1.5 h

Learning outcomes:

  • Describe IQ/OQ/PQ expectations for radiation sterilization facilities and contract sterilizers.
  • Define acceptance criteria for dose mapping and verification dose experiments.
  • Assemble an audit-ready validation package (protocol + raw data traceability + report).

Content outline:

  • IQ topics: equipment/specifications, calibration, dosimetry system qualification, software controls, safety interlocks.
  • OQ topics: dose delivery characterization, conveyor settings (e-beam/x-ray), source/rack configuration (gamma), alarms, and process limits.
  • PQ elements: dose mapping execution, verification dose experiment execution, and interpretation.
  • Handling deviations: out-of-spec dose, dosimeter anomalies, load changes, and investigation approach.
  • Validation report essentials: summary tables, justification of conclusions, and link to routine control plan.

Workshop / exercise:

Case study: review a simplified dose mapping data set and decide if acceptance criteria are met; identify missing evidence for an audit.

Expected outputs:

  • Decision record with justification
  • List of required objective evidence to complete the validation file
A4. Radiation Sterilization – Routine Control and Maintaining Effectiveness

Suggested duration: 1.5 h

Learning outcomes:

  • Set up routine monitoring and control: dosimetry, process parameters, and release decisions.
  • Define periodic dose audits and requalification triggers.
  • Use trending and change control to maintain effectiveness through the product lifecycle.

Content outline:

  • Routine control framework: process specification, routine monitoring, and product release.
  • Routine dosimetry: placement, frequency, dosimeter handling, and acceptance criteria for minimum/maximum dose.
  • Dose audit concepts: periodic verification of sterilization dose; handling shifts in bioburden/resistance trends.
  • Process deviations and nonconforming product control: containment, disposition, and CAPA linkage.
  • Maintaining effectiveness: change control triggers (packaging, density, pallet pattern, source movement, equipment changes), revalidation decisions.
  • Management review inputs: KPI examples (dose excursions, audit results, CAPA, lab OOS rates).

Workshop / exercise:

Workshop: create a routine control plan and a requalification decision tree for common changes (packaging, load density, new product variant).

Expected outputs:

  • Routine control plan template completed
  • Requalification decision tree (site specific)
B1. EO Sterilization – Validation Planning (ISO 11135:2014)

Suggested duration: 1.5 h

Learning outcomes:

  • Define the EO sterilization process and critical process parameters (CPPs) and their control strategy.
  • Develop a product/load configuration strategy including worst-case selection and product families.
  • Plan microbiological performance evaluation and define acceptance criteria for sterilization efficacy.

Content outline:

  • EO process overview: conditioning, pre-vacuum, EO injection, exposure, post-vacuum/air washes, aeration.
  • CPPs and their rationale: temperature, relative humidity, EO concentration, time, pressure, gas distribution, and load design.
  • Product and load definition: packaging, lumens, absorbent materials, and load density considerations.
  • Microbiology inputs: bioburden considerations, biological indicators (BIs) selection/placement rationale (high-level).
  • Validation planning: protocol structure, worst-case rationale, sampling, and responsibilities (sterilizer, lab, QA).
  • Data integrity and traceability: cycle records, sensor calibration, BI/CI control, and lab chain of custody.

Workshop / exercise:

Workshop: define a worst-case product/load and map CPPs to risks. Draft acceptance criteria for the EO validation protocol.

Expected outputs:

  • Worst-case selection rationale
  • Draft acceptance criteria table for CPPs and microbiological outcomes
B2. EO Sterilization – Installation/Operational/Performance Qualification (IQ/OQ/PQ)

Suggested duration: 1.5 h

Learning outcomes:

  • List IQ/OQ requirements for EO sterilization equipment, utilities, and safety systems.
  • Explain PQ concepts such as half-cycle/full-cycle approach and product/load qualification (including MPQ/PPQ where applicable).
  • Identify common deviations and define investigation/impact assessment approach.

Content outline:

  • IQ topics: equipment specification, piping & instrumentation, leak tests, EO supply system, aeration room qualification, software and access controls.
  • Safety and environmental controls: ventilation, gas monitoring, abatement, emergency response interfaces (site specific).
  • OQ topics: empty chamber and loaded chamber studies, distribution of temperature/humidity/EO concentration, alarm and interlock testing.
  • PQ topics: microbiological performance demonstration, BI placement rationale, half-cycle/full-cycle approach (conceptual), product/load performance qualification.
  • Aeration effectiveness: ensuring EO residual reduction and demonstrating control of aeration time/conditions.
  • Protocol/report expectations: predefined acceptance criteria, raw data, deviations, and conclusion logic.

Workshop / exercise:

Case study: software change or sensor replacement scenario. Decide whether partial requalification is sufficient or PQ repetition is required, and justify using risk and evidence.

Expected outputs:

  • Requalification scope justification
  • List of required tests/records for the proposed change
B3. EO Sterilization – Routine Control and Release Decision-Making

Suggested duration: 1.25-1.5 h

Learning outcomes:

  • Establish routine monitoring of CPPs and define batch release criteria.
  • Differentiate routine monitoring tools (cycle record review, CIs, BIs, PCDs) and their roles.
  • Handle deviations, reprocessing, and product disposition under an ISO 13485-compliant nonconformity process.

Content outline:

  • Routine control plan: cycle parameter limits, sensor checks, and load pattern control.
  • Routine indicators: use of CIs, BIs (if applicable), PCD concepts, and sampling governance.
  • Release approaches: parametric release concepts and prerequisites (high-level) versus BI-based release; risk-based selection.
  • Deviation handling: cycle aborts, EO concentration/temperature excursions, humidity issues, BI positives, and quarantine rules.
  • Reprocessing and re-sterilization: technical considerations and documentation controls.
  • Trending and periodic review: cycle capability, drift, and recurring alarms/deviations.

Workshop / exercise:

Workshop: build a deviation decision flow (containment to disposition) for three scenarios: humidity low, EO concentration low, BI positive.

Expected outputs:

  • Deviation decision flowchart
  • Draft quarantine/rework disposition checklist
B4. EO Sterilization – Maintaining Effectiveness (Requalification, Residuals, and Lifecycle Management)

Suggested duration: 1.25 h

Learning outcomes:

  • Define triggers and frequency for requalification of EO process and associated systems.
  • Explain how EO residuals (ISO 10993-7) link to process changes and ongoing effectiveness.
  • Integrate environmental, occupational safety, and facility controls into maintaining effectiveness.

Content outline:

  • Requalification triggers: product changes (materials, packaging, lumens), load configuration changes, equipment/software changes, utility changes, facility modifications.
  • Periodic requalification concepts: sensor calibration review, distribution studies (as needed), microbiological performance checks (as applicable).
  • EO residuals overview: patient safety rationale and how changes can affect residual profiles (conceptual).
  • Aeration control and monitoring: ensuring consistent residual reduction; managing worst-case product families.
  • Environmental and safety considerations: gas monitoring, emission controls, training/competency, emergency preparedness (site specific).
  • Management review and continual improvement: KPIs, CAPA effectiveness, supplier performance, and audit findings.

Workshop / exercise:

Group discussion: define your site’s top revalidation triggers and propose a yearly effectiveness review checklist for EO.

Expected outputs:

  • EO effectiveness review checklist
  • List of revalidation triggers tailored to the site

 

Interested with this course? Send us enquiries below!

Enquiry Now!